U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Qatar LNG Tanker Crosses Strait of Hormuz Amid Iran War Tensions
Dominican Republic Halts GoldQuest Mining Project Amid Environmental Protests
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
U.S., South Korea Launch Shipbuilding Partnership Initiative
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Rubio Approves $25.8 Billion Weapons Sale to Middle East Allies
Israel’s Secret Iraq Base Allegedly Supported Iran Air Campaign, WSJ Reports
Russian LNG Shadow Fleet Expands Amid Arctic LNG 2 Sanctions
Qatar Condemns Drone Strike as Iran Conflict Threatens Gulf Shipping and Global Markets 



